Diagnostic Kits/Data, narratives and tools produced by the Kits' sector: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 13: Line 13:
* products
* products
*: BRACAnalysis ($3120) - includes BRCA1 & BRCA2
*: BRACAnalysis ($3120) - includes BRCA1 & BRCA2
{|
|-
!Gene
!
|-
|Patent Holders
|
|-
|Key Patents
|
|-
|Other Patents
|
|-
|Licenses
|
|-
|US Test providers
|
|-
|Test cost
|
|}
{|
|-
!Gene
!
|-
|Patent Holders
|
|-
|Key Patents
|
|-
|Other Patents
|
|-
|Licenses
|
|-
|US Test providers
|
|-
|Test cost
|
|}


=== BRCA2 ===
=== BRCA2 ===

Revision as of 18:10, 23 November 2009

Types of inputs for kits

Genetic Diagnostic Case Studies

The following are summaries of IP and commercialization information of commercially available diagnostic kits. A subset of this list will be developed into more extensive case studies. The old spreadsheet form of this information is available here.

Breast and Ovarian Cancer

BRCA1

  • Patent Holders
    Myriad Genetics (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    BRACAnalysis ($3120) - includes BRCA1 & BRCA2
Gene
Patent Holders
Key Patents
Other Patents
Licenses
US Test providers
Test cost



Gene
Patent Holders
Key Patents
Other Patents
Licenses
US Test providers
Test cost

BRCA2

  • Patent Holders
    Myriad Genetics (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    BRACAnalysis ($3120) - includes BRCA1 & BRCA2

References

Main Page Diagnostic_Kits

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Data,_narratives_and_tools_produced_by_the_Kits%27_sector&oldid=5394"